首页> 美国卫生研究院文献>Indian Journal of Surgical Oncology >Validation of Contrast Enhanced Ultrasound Technique to Wire Localization of Sentinel Lymph Node in Patients with Early Breast Cancer
【2h】

Validation of Contrast Enhanced Ultrasound Technique to Wire Localization of Sentinel Lymph Node in Patients with Early Breast Cancer

机译:对比增强超声技术对早期乳腺癌患者前哨淋巴结线定位的验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Axillary staging is one of the primary steps in management of Breast cancer patients. Current standard methods including blue dye and radicolloid have limitations and disadvantages. In this study, the feasibility of visualization of lymph node pathways and localization of SLN with the help of CEUS was assessed. 50 patients with early breast cancer diagnosis underwent CEUS and wire localization, methylenblue dye, and isotope scan methods for SLN detection. The pathology findings of the wired SLN were compared with those obtained from, methylenblue dye, and isotope scan methods. Lymph node wiring was successfully performed in 48 patients.Radio-isotope technique detected SLN in all 50 patients while blue-dye succeeded in 48. Sensitivity of CEUS to detect SLN compared with radio-isotope and blue dye methods was 96 % and 100 %, respectively. Considering costs and facilities required to perform radio-isotope technique and complications of blue dye we may accept CEUS with the help of micro-bubble contrasts as a viable alternative. However, more studies with larger sample volumes, using various drugs, and including non-selective population are warranted to better clarify feasibility and accuracy of this technique in comparison with current methods.
机译:腋窝分期是治疗乳腺癌患者的主要步骤之一。当前的标准方法包括蓝色染料和放射性胶体具有局限性和缺点。在这项研究中,评估了借助CEUS可视化淋巴结途径和SLN定位的可行性。对50例早期诊断为乳腺癌的患者进行了CEUS和导线定位,亚甲基蓝染料以及同位素扫描方法进行SLN检测。将有线SLN的病理结果与从亚甲基蓝染料和同位素扫描方法获得的结果进行比较。 48例患者成功完成了淋巴结布线。放射性同位素技术在所有50例患者中检测到SLN,而蓝染技术成功检测到48例。CEUS检测SLN的敏感性与放射性同位素和蓝色染料方法相比为96%和100%,分别。考虑到执行放射性同位素技术所需的成本和设施以及蓝色染料的复杂性,我们可以接受微气泡造影剂作为CEUS的可行选择。但是,与现有方法相比,有必要进行更多的研究,以更大的样本量,使用各种药物,包括非选择性人群,以更好地阐明该技术的可行性和准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号